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OBJECTIVES The purpose of the present study was to compare the long-term clinical and echocardio-
graphic results of the Inoue and the double-balloon techniques.
BACKGROUND The large randomized trial comparing the extent of commissurotomy and the long-term
results between the double-balloon and Inoue balloon techniques has not been reported.
METHODS We conducted a prospective, randomized trial comparing two procedures in 302 consecutive
patients who underwent percutaneous mitral valvuloplasty (PMV) using Inoue (n 5 152;
group I) or double-balloon technique (n 5 150, group D) between 1989 and 1995. The
sample size was planned to provide the study with approximately 80% power for the detection
of a 10% difference between the two groups.
RESULTS There were no significant differences in baseline characteristics between the two groups.
Immediately after PMV, mitral valve area (MVA) increased from 0.9 6 0.2 to 1.8 6 0.3 cm2
in group I and from 0.9 6 0.2 to 1.9 6 0.3 cm2 in group D. No significant differences existed
between the two groups in terms of development of commissural splitting, commissural mitral
regurgitation (CMR), moderate to severe mitral regurgitation (MR) and MVA after PMV.
The successful immediate results (MVA $1.5 cm2 and MR #2) were achieved in 127 (84%)
patients of group I and 122 (81%) patients of group D (p 5 NS). Annual clinical and
echocardiographic evaluation was completed for 290 (96%) patients with mean follow-up of
51 6 27 months. Adverse events occurred in 19 (13%) patients of group I (3 deaths, 7 mitral
valve replacements, 5 repeat PMV, 2 NYHA class $3, 2 technical failures) and 16 (11%)
patients of group D (2 deaths, 10 mitral valve replacements, 3 repeat PMV, 1 NYHA class
$3). Estimated actuarial seven-year event-free survival was 75 6 7% in group I and 82 6 6%
in group D (p 5 NS). Estimated actuarial seven-year restenosis-free survival was 67 6 7% in
group I and 76 6 6% in group D (p 5 NS). On multivariate analysis, unsuccessful immediate
result (p , 0.001) and absence of CMR (p , 0.01) were independently related with events.
Absence of CMR and smaller mitral valve area after PMV were independently related with
restenosis (p , 0.001).
CONCLUSIONS The Inoue and double-balloon techniques were equally effective in commissurotomy and
produced similar, excellent long-term results. The achievement of complete commissurotomy
with development of CMR or larger post-PMV mitral valve area is important to optimize the
long-term results of PMV. (J Am Coll Cardiol 2000;35:169–75) © 1999 by the American
College of Cardiology
Percutaneous mitral valvuloplasty (PMV) using the double-
balloon and Inoue balloon techniques has been accepted as
an effective procedure for treatment of severe mitral stenosis
(MS) (1–6), and both techniques yielded clinical and
hemodynamic improvements on immediate and short-term
results after PMV (7–12). However, large randomized trials
comparing the long-term results of the double-balloon
technique and the Inoue balloon technique have not been
reported to date. Previous studies suggest that commissural
splitting is the major determinant of successful PMV
(13–15). Because the dilating instruments are different
between the double-balloon and Inoue balloon techniques,
the dilating force applied to the fused commissure and the
extent of commissural splitting after PMV may be different.
It has also not been known whether commissurotomy
should be extensive enough to cause the development of
commissural mitral regurgitation (CMR) or limited only to
split fused commissure without causing the development of
CMR.
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Anatomical restenosis as determined by echocardiogra-
phy was not always associated with recurrence of symptoms,
and the time to restenosis was difficult to determine clini-
cally. Both echocardiographic and clinical follow-up are
necessary to assess the true incidence of restenosis after
successful PMV, but only a few studies have reported the
results of echocardiographic follow-up for two years
(16–18). The primary goal of this prospective randomized
trial was to compare the extent of commissurotomy, imme-
diate and long-term clinical, echocardiographic results be-
tween double-balloon and Inoue balloon techniques, and a
secondary goal was to relate the extent of commissurotomy
after PMV with the clinical events and echocardiographic
restenosis.
METHODS
Study population. From September 1989 to December
1995, a total of 302 consecutive patients (77 men, mean age
41 6 11 years) were randomly assigned to either the
double-balloon method (n 5 150; group D) or the Inoue
balloon method (n 5 152; group I). The criteria for
inclusion in the study were defined as moderate to severe
MS (mitral valve area [MVA] #1.2 cm2) patients with
symptom of New York Heart Association (NYHA) func-
tional class II to IV, atrial fibrillation, pulmonary hyperten-
sion or previous history of embolism. Patients with total
echocardiographic score .10, mitral regurgitation (MR)
$grade 3, left atrial thrombi or significant aortic valvular
disease were excluded. Informed consent was obtained from
all patients, and the study protocol was approved by the
ethical committee of our institution.
PMV. After cardiac catheterization confirmed severe MS
without significant MR, the randomization envelope was
opened. The PMV was performed using either the double-
balloon or the Inoue balloon technique as previously de-
scribed (12). Every procedure was done by two experienced
physicians (S.J.P. and S.W.P.), and conventional hemody-
namic parameters were monitored. To minimize the effects
of the balloon size and dilation technique on the extent of
commissurotomy, we chose the same size balloon and the
same dilation technique in both PMV groups. Balloon size
was chosen to obtain the value of effective balloon dilating
area/body surface area (EBDA/BSA) at approximately
4 cm2/m2, and one-step dilation was performed in both
techniques (12).
Echocardiographic evaluation. Two dimensional echo-
cardiography and Doppler color flow imaging were per-
formed in all patients on the day before and 24 h after
PMV, using a Hewlett-Packard Sonos 1000 or 2500 imag-
ing system equipped with a 2.5-MHz transducer. Trans-
esophageal echocardiography was also carried out in all
patients to exclude left atrial thrombus. All the echocardio-
graphic examinations were recorded on super VHS video-
tapes and reviewed by two experienced physicians (D.H.K.
and J.K.S.). The morphological features of the mitral valve
were categorized as previously described (19), and the total
echocardiographic score was obtained by adding the score
for each of the following individual morphologic features:
leaflet mobility, thickness, calcification, and subvalvular
lesions. The MVA was measured by direct planimetry of
mitral orifice before PMV. Mitral regurgitation was de-
tected and semiquantitatively graded with color flow imag-
ing (20).
On the next day after PMV, the MVA was measured by
direct planimetry, and successful immediate results of PMV
were defined as MVA $1.5 cm2 and MR grade #2.
Commissural splitting after PMV was determined from
examination of the parasternal short-axis view and defined
as either an increased apparent opening angle of either
commissure (15) or increased leaflet separation associated
with an increased transverse diameter of the orifice, or both
(17). The extent of the commissurotomy by PMV was
quantified by the increase of transverse diameter of the
orifice and the development of CMR. Development of
CMR was determined from examination of the parasternal
short-axis view and the apical two-chamber view by two
independent observers (D.H.K. and J.K.S.), and CMR was
defined as MR originating from medial or lateral commis-
sure on color flow imaging and regarded as an index of
complete commissural splitting (Fig. 1). The two observers
disagreed as to whether CMR occurred in nine (3%) cases,
and the final decision was reached based on the presence or
the absence of CMR in the follow-up echocardiographic
study performed one year later.
Follow-up studies. Clinical follow-up was performed at
two months and six months after PMV and every year until
December 1997. Clinical data were collected either during
patient visits to the department or by telephone interviews.
The primary end points were defined as the clinical events of
death, mitral surgery, repeat PMV, and deterioration of
NYHA functional class $3. Echocardiographic follow-up
data were obtained at one-year intervals until December
1997. The secondary end point was echocardiographic
restenosis defined as a MVA #1.5 cm2 with loss of initial
gain in MVA $50%. Clinical and echocardiographic
follow-up was completed for 287 patients (96%) with a
Abbreviations and Acronyms
BSA 5 body surface area
CMR 5 commissural mitral regurgitation
EBDA 5 effective balloon dilating area
group D 5 double-balloon group
group I 5 Inoue balloon group
MR 5 mitral regurgitation
MS 5 mitral stenosis
MVA 5 mitral valve area
NYHA 5 New York Heart Association
PMV 5 percutaneous mitral valvuloplasty
170 Kang et al. JACC Vol. 35, No. 1, 2000
Inoue Versus Double Balloon PMV January 2000:169–75
mean follow-up period of 51 6 27 months (up to eight
years).
Statistical analysis. The long-term incidence of clinical
events after PMV in patients with favorable morphology of
mitral valve ranges from 5% to 10% (21–23). Approximately
150 patients are needed in each group to detect a 10%
difference between two groups with a power of 80% and a
type I error of 5% (two-sided). The primary analysis of
clinical and echocardiographic outcomes was based on the
intention-to-treat principle. Numerical values were ex-
pressed as mean 6 SD. Continuous variables were com-
pared using the Student unpaired t test. The chi-square test
compared frequency ratios between groups. Kaplan-Meier
analysis was used to determine survival rate, event-free
survival rate and restenosis rate. Differences in survival rates
between the two groups were examined with the log-rank
test. The clinical and echocardiographic variables were
evaluated by Cox regression analysis to identify predictors of
event-free survival and restenosis. The variables included in
the analysis were age, gender, pre-PMV NYHA class,
cardiac rhythm, balloon technique, echocardiographic score,
pre- and post-PMV MVA and transmitral gradients, de-
velopment of commissural splitting and CMR, and achieve-
ment of immediate successful result after PMV.
RESULTS
Baseline characteristics. Three hundred and two patients
were randomly assigned to group I or to group D. Baseline
clinical, echocardiographic and hemodynamic characteris-
tics of the study population are summarized in Table 1. No
significant differences existed between group I and group D
patients in terms of age, gender ratio, NYHA functional
class, cardiac rhythm, total echocardiographic score, MVA
and mitral valve gradient.
Immediate outcome. Percutaneous mitral valvuloplasty
was completed successfully in all 150 patients of group D
and in 149 of 152 patients of group I; one death during
emergency operation after unsuccessful balloon deflation
and two cases of unsuccessful mitral valve crossing occurred
in group I. In group I, the total procedure time was 41 6
16 min, which was significantly shorter than that of group
D (50 6 17 min, p , 0.01). The balloon size was similar in
both techniques: the mean value of EBDA/BSA was 3.9 6
0.3 cm2/m2 in both groups. In group I, the mean height of
the patients was 159 6 8 cm, the mean BSA was 1.57 6
0.15 m2, and the diameter of the balloons ranged from 24 to
30 mm. The actual balloon size adjusted by BSA in group
I was significantly larger than the recommended initial
reference size adjusted by height (27.9 6 1.0 vs. 25.9 6
0.8 mm, p , 0.001). The PMV resulted in a significant
increase of MVA from 0.9 6 0.2 to 1.8 6 0.3 cm2 (p ,
0.001) in group I, and from 0.9 6 0.2 to 1.9 6 0.3 cm2 (p ,
0.001) in group D, and a significant decrease of transmitral
pressure gradient in both groups (16 6 6 to 7 6 3 mm Hg
[p , 0.001] in group I and 17 6 7 to 6 6 4 mm Hg [p ,
0.001] in group D). There were no significant differences
between the two groups in terms of MVA and mean mitral
gradient after PMV. MVA $1.5 cm2 was achieved in 137
(90%) patients of group I and 132 (88%) patients of group
D (p 5 NS). Of the patients who had a MVA $1.5 cm2,
Figure 1. Both commissural splitting and commissural mitral regurgitation after successful PMV on parasternal short axis view (A and B)
and apical two-chamber view (C). The arrows indicate split commissures (A) and origination of MR from both commissures (B and C).
IVS, interventricular septum; LA, left atrium; LV, left ventricle; MV, mitral valve; MVO, mitral valve orifice; RV, right ventricle.
Table 1. Baseline Characteristics of Patients Who Underwent
Inoue or Double-Balloon Percutaneous Mitral Valvuloplasty
Inoue
Balloon
(n 5 152)
Double
Balloon
(n 5 150)
Age, years 42 6 11 40 6 11
Gender (males/females, n) 37/115 40/110
NYHA functional class, n
I 13 16
II 64 55
III 67 73
IV 8 6
Rhythm, n
Sinus 87 93
Atrial fibrillation 65 57
Echocardiographic data
MVA (cm2) 0.9 6 0.2 0.9 6 0.2
Total echocardiographic score 7.8 6 1.5 7.7 6 1.4
Hemodynamic variables (mm Hg)
Systolic PAP 35 6 15 33 6 11
Transmitral pressure gradient 16 6 7 17 6 7
NYHA 5 New York Heart Association; MVA 5 mitral valve area; PAP 5
pulmonary arterial pressure. Continuous variables are expressed as mean 6 SD.
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MR grade $3 occurred in 10 patients of group I and 10
patients of group D. Thus, the successful immediate results
were achieved in 127 (84%) patients of group I and 122
(81%) patients of group D (p 5 NS). The multiple logistic
regression analysis identified lower total echo score and
larger pre-PMV MVA as the independent predictors of
successful immediate results (p , 0.001).
Commissural splitting. Splitting of one or both commis-
sures was observed in 147 (97%) patients of group I and
143 (95%) patients of group D (p 5 NS). Commissural
splitting was observed in 246 of 249 patients with a
successful immediate outcome and in 24 (80%) of 30
patients with post-PMV MVA ,1.5 cm2 (p , 0.001). The
extent of commissurotomy was evaluated using the change
of transverse diameter of mitral valve orifice and develop-
ment of CMR after PMV. The mean changes in transverse
diameter of mitral valve orifice after PMV were 0.6 6
0.2 cm in group I and 0.6 6 0.3 cm in group D, and the
increase of transverse diameter by PMV was not signifi-
cantly different between the two groups. Commissural
mitral regurgitation was observed in 78 (51%) patients of
group I and 80 (53%) patients of group D. The severity of
CMR was #grade 2 in 148 (94%) patients and grade 3 in 10
(6%) patients. No patients with grade 3 of CMR required
operation.
Follow-up. There were two patient deaths in group I:
one patient died at three months after PMV during
mitral valve replacement due to flail mitral valve with
severe MR, and the other patient with post-PMV MVA
of 1.2 cm2 died four years after PMV. In patients of
group D, there were two deaths from restenosis at five
years and seven years after PMV. The survival rate at
seven years was 97 6 2% in group I and 99 6 1% in group
D (p 5 NS). In group I, mitral valve replacement was
performed in seven cases, repeat PMV in five cases and
deterioration of NYHA functional class $3 occurred in
two cases during mean follow-up of 51 6 26 months. In
group D, mitral valve replacement occurred in 10 cases,
repeat PMV in three cases and deterioration of dyspnea
in one case during mean follow-up of 50 6 28 months.
The atrial septal defects with left-to-right shunt on color
flow imaging persisted in four patients of group I and 10
patients of group D (p 5 NS) during follow-up. No
patient required early or late surgical closure due to
left-to-right interatrial shunt. The cerebral infarctions
occurred in one patient of group I and in three patients of
group D during follow-up. The probability of event-free
survival in group I was 97 6 2% at three years, 91 6 3%
at five years and 75 6 7% at seven years and in group D,
98 6 1% at three years, 92 6 3% at five years and 82 6
6% at seven years, respectively (Fig. 2A). Cox regression
analysis demonstrated that echocardiographic score, pre-
and post-PMV MVA, development of CMR and com-
missural splitting, calcification of mitral valve and
achievement of immediate successful result after PMV
were significantly related with the incidence of events at
follow-up. Multiple Cox stepwise regression analysis
identified that immediate unsuccessful result (p , 0.001)
and absence of CMR (p , 0.01) after PMV were directly
and independently related with the clinical events.
Among 249 patients with successful immediate results
after PMV (MVA $1.5 cm2 and MR grade #2), echocar-
diographic restenosis occurred in 22 (17%) patients of group
I and in 16 (13%) patients of group D during follow-up.
Figure 2. Comparison of the event-free (A) and restenosis-free survival rate (B) after PMV between Inoue technique and double-balloon
technique.
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The estimated actuarial seven-year restenosis-free survival
rate was 67 6 7% in group I and 76 6 6% in group D,
respectively (p 5 NS) (Fig. 2B). Multiple stepwise Cox
regression analysis identified that absence of CMR and
smaller post-PMV MVA were the only two independent
predictors of echocardiographic restenosis (p , 0.001).
The estimated actuarial seven-year event-free survival
rate (84 6 5%) in patients with successful immediate results
after PMV was significantly better than that in patients with
poor immediate results due to insufficient valve opening or
severe MR (54 6 9%) (Fig. 3). The estimated actuarial
seven-year event-free survival was also significantly different
between the patients with restenosis (43 6 12%) and those
without restenosis (92 6 3%). As decrease in MVA oc-
curred gradually after PMV, no patients with echocardio-
graphic restenosis required emergency reinterventions due
to abrupt deterioration of symptoms. The symptomatic
improvement by PMV persisted in 29 (63%) of 46 patients
with restenosis. These asymptomatic patients with resteno-
sis had a significantly larger MVA at follow-up study than
did those who needed mitral valve surgery or PMV (1.2 6
0.1 cm2 vs. 0.9 6 0.2 cm2, p , 0.001).
Development of CMR was the significant independent
predictor of event-free and restenosis-free survival, and the
serial post-PMV MVAs were significantly different between
the patients with and without CMR after PMV (Fig. 4).
The annual decrease of post-PMV MVA was also signifi-
cantly smaller in the patients with, than those without,
CMR (0.06 6 0.12 vs. 0.12 6 0.16 at one year, p , 0.001;
0.03 6 0.07 vs. 0.06 6 0.10 at two years, p 5 0.005; 0.02 6
0.05 vs. 0.07 6 0.10 at three years after PMV, p , 0.001,
respectively). Among 39 patients with CMR $2, CMR
decreased in 13 (33%) cases, did not change in 22 (57%)
cases, and progressed to moderate MR in four (10%) cases.
Progression to severe MR requiring mitral valve surgery was
not observed in follow-up studies.
DISCUSSION
Inoue versus double-balloon technique. The Inoue
single-balloon technique differs from the double-balloon
technique in several important aspects. The Inoue technique
is easier to perform and needs shorter total procedure and
fluoroscopic times (7,12,24), and in this study the procedure
time was also significantly shorter in the Inoue balloon than
Figure 3. Actuarial curves showing the event-free survival rate
according to the immediate result after PMV. Successes and
failures were classified according to the immediate results of PMV.
“Success” was defined as post-PMV MVA $1.5 cm2 and MR #2,
and “Failure” defined as post-PMV MVA ,1.5 cm2 or MR $3.
Figure 4. Comparison of the restenosis-free survival rate (A) and
serial changes of MVA (B) after PMV between the patients with
and without commissural MR (CMR); the patients with develop-
ment of events during follow-up were excluded in the comparison
of mitral valve area. Presence (1) vs. absence (2) of CMR; *p ,
0.05; †p , 0.01; ‡p , 0.001 by t test.
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in the double-balloon technique. The dilating shape
achieved in the Inoue balloon is circular and different from
the elliptic dilating shape achieved in the double-balloon. It
has not been known whether different dilating shapes in the
two techniques might produce differences in extent of
commissurotomy and whether that might result in different
incidences of restenosis and cardiac events. There is con-
troversy as to whether the Inoue and the double-balloon
techniques provide similar immediate and long-term results
(11,12,25–27). In this randomized trial, we compared clin-
ical and echocardiographic results of the Inoue balloon and
the double-balloon technique for up to eight years, and we
minimized the effects of balloon size and dilation technique
by choosing balloons with similar EBDAs and by using a
one-step dilation technique in both groups. Our study
demonstrates that the Inoue and double-balloon methods
resulted in similar long-term outcomes in terms of survival,
cardiac events and echocardiographic restenosis.
Long-term outcomes. In this study, the overall actuarial
seven-year survival and event-free survival rates were excel-
lent and might be better than those of others (22,23,28).
The ages of our patients were 41 6 11 years, and patients
with severe deformity of mitral valve were excluded in this
study. Because old age, high echocardiographic score, fluo-
roscopic calcification and commissural calcification are
known as important risk factors for the immediate and
long-term outcomes of PMV (29–32), these differences of
clinical characteristics and mitral valve morphology in each
study should be considered in comparison with the results of
PMV.
We found that achievement of successful immediate
results and development of echocardiographic restenosis
after PMV were significantly related to long-term outcomes
of PMV. Previous studies also reported post-PMV MVA
and restenosis as significant independent predictors of the
long-term results of PMV (6,31–33). Immediate success
was related with clinical and echocardiographic characteris-
tics of the patients, such as total echocardiographic score
and pre-PMV MVA, but echocardiographic restenosis was
more related to procedural variables, such as post-PMV
MVA and development of CMR after PMV. These find-
ings suggested that complete commissurotomy with larger
MVA or CMR may prevent fibrous fusion of split commis-
sure (34) and restenosis. Both the Inoue and double-balloon
techniques obtained a similar extent of commissurotomy
based on a similar incidence of CMR and the same change
in MVA and transverse diameter of the mitral valve orifice
after PMV. The similar extent of commissurotomy in both
techniques may explain the similar long-term results in
terms of restenosis and cardiac events.
The annual echocardiographic follow-up data suggested
that the natural course of most CMR was benign during
follow-up and that the rate of decrease in MVA after PMV
was significantly slower in patients with CMR compared
with those without CMR. Previous studies also reported
that the mechanisms of development of MR after PMV
were different for mild and severe MR. Mild MR was
produced by complete commissurotomy, but severe MR was
produced by leaflet tears or chordal rupture (35–37). The
mechanism by which CMR maintains initial gain in MVA
is unclear. The decrease in MVA after PMV may be related
to fusion of split commissure and recoil of the stretch
component. Complete commissurotomy and CMR might
prevent immediate recoil and late fusion by preventing
apposition of split commissures.
Study limitations. In this study we chose the same dilation
technique and the same balloon size in both groups to
differentiate the effects of dilating instruments from those of
dilation technique and balloon size. In group I, the balloon
sizes were larger than the initial reference balloon sizes
adjusted by height, and the dilation technique was also
different from the more commonly used stepwise dilation
technique (38). For the patients with severe deformity of
mitral valve, stepwise dilation with the smaller initial bal-
loon size may have the advantage of avoiding occurrence of
severe MR (21,38). Because we speculated that in the
patients with favorable morphology of mitral valve, one-step
dilation with the maximal recommended size of the balloon
(39) could achieve commissurotomy in the largest number
of patients without increasing the risk of severe MR and also
decrease procedure time compared with stepwise dilation
technique, the study population was limited to patients with
an echocardiographic score #10, and one-step dilation
technique was chosen in this study. It is also unclear
whether the stepwise dilation technique would be better in
long-term results than would the one-step dilation, because
the stepwise dilation with inadequate initial inflation vol-
ume might decrease CMR as well as severe MR and result
in ineffective commissurotomy and early restenosis due to
recoil of stretched leaflets. It was reported that the incidence
of severe MR was lower if balloon sizes were chosen so that
EBDA/BSA #4 cm2/m2 and the optimal EBDA/BSA was
between 3.1 and 4.0 cm2/m2 (39). The balloon size chosen
in this study might be oversized for the patients with high
echocardiographic score or high risk of post-PMV MR
(40).
In conclusion, this study demonstrates that both the
Inoue technique and the double-balloon technique were
equally effective in commissurotomy and produced similar
and excellent long-term results. Whether the PMV is
performed using the Inoue balloon or the double-balloon
technique, the achievement of complete commissurotomy
with development of CMR or larger MVA is important in
optimizing the long-term results of PMV.
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